The HPV Vaccine Effectiveness Project
Infections with some types of human papillomavirus (HPV) cause cervical cancer. The HPV vaccine is recommended for routine administration to adolescents starting at ages 11-12 years and for women up to 26 years of age who have not recieved the vaccine. This vaccine can prevent infection caused with the HPV types that can cause cervical cancer. The HPV Vaccine Effectiveness Project is a study that aims to learn how well the HPV vaccine works in the real world and how important it is to give the vaccine in early adolescence.
- HPV (human papillomavirus) is a common virus. There are more than 100 different types of HPV, many of which can infect the genital area.
- Genital HPV is passed from skin to skin genital contact. Most infected individuals do not realize they are infected.
- Genital HPV is linked to various types of genital cancer, cervical cancer being the most common type of genital cancer.
- Every year, there are 11,500 cases of cervical cancer and over 4,000 deaths in the United States alone.
- Since 2006, three vaccines have been licensed in the US that can protect against infection with the types of HPV that cause most cases of cervical cancer.
- Is the Vaccine Safe?
- The HPV vaccine is very safe, and it is effective at preventing HPV. Vaccines, like any medicine, can have side effects. Many people who get the HPV vaccine have no side effects at all. Some people report having very mild side effects, like a sore arm from the shot. The most common side effects are usually mild.
- For more information see links below